PATENT CLAIM ANALYSIS

Application Number: 16201011
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["606", "152000"]

Abstract:
The present disclosure is directed to the use of fusogenic compounds such as polyethylene glycol (PEG) in combination with antioxidants, calcium-containing and calcium-free solutions for treating damaged nerves, such as for reconnecting severed nerves.

Claim (Index 37):
A method of coaptation of a human first nerve segment having a first end and a human second nerve segment having a second end, comprising the steps of:\n a) applying a hypotonic, calcium-free saline solution to said first and second nerve segments for a first period of time; b) bringing into contact said first and second nerve ends; c) optionally, after step a), applying to said nerve segments a solution containing an antioxidant inhibitor of membrane sealing; d) applying a lipid membrane fusogen solution to said contacted first and second nerve segments; d) applying to the contacted nerve segments an isotonic, calcium-containing solution to thereby coapt said contacted nerve first and second nerve segments.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 98.0
- Lexical Diversity: 1.14706
- Patent Class: 606.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15597891', '14001431', '10812776', '10218864', '10218316']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7135611146795142
- 35 USC 102 Novelty (BERT): 0.5843808210401958
- Combined Prediction Score: 0.7006430853155824
- Mean Citation Score: 276.638074
- Max Citation Score: 511.98962
- Similarity Product: 485.4479217742442

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test